What are the key links to control the biological safety of collection sites and testing laboratories?

The treatment of medical waste is a key link to control the biological safety of collection sites and testing laboratories.

Medical waste treatment. Every step of nucleic acid detection will produce medical waste. Do a good job in the collection, packaging, harmless treatment, temporary storage, handover and transfer of medical wastes. Use double-layer packaging bags to contain medical wastes and seal them effectively, so as to ensure that the sealing is tight and the packaging of medical wastes is not damaged or leaked.

1, basic requirements. COVID-19 sample collection points and laboratories carrying out nucleic acid detection should formulate medical waste disposal procedures. All medical wastes must be identified in accordance with unified and standardized containers and identification methods, and the waste content must be identified completely and meet the requirements. Medical waste should be treated by trained personnel using personal protective equipment and devices.

2, medical waste treatment measures. The treatment of medical waste is a key link to control the biological safety of collection sites and testing laboratories. We must fully grasp the classification related to biosafety and strictly implement the corresponding treatment procedures.

Guide to Organization and Implementation of Nucleic Acid Detection in novel coronavirus for All Employees (Second Edition)

Form a work team.

1, set up teams of nucleic acid sampling, sample delivery, nucleic acid detection, technical support of information platform and corresponding emergency response at all levels, define the responsible area of sampling and detection, and make sure that when the whole people in the province start nucleic acid detection, they will immediately put into work. All emergency teams are guaranteed to be on standby 24 hours a day, making all preparations for starting at any time.

2. Set up a nucleic acid sampling steering group to patrol and guide each sampling point in the form of piecemeal contract, standardize sampling, personal protection and cross-infection prevention and control, find and solve problems in time, and ensure high quality and efficiency of sampling.

3. Establish a nucleic acid detection supervision team, organize clinical laboratory experts to establish a patrol supervision mechanism, inspect laboratories, and supervise third-party nucleic acid detection institutions.

4, the establishment of data classes, centralized management of nucleic acid detection information, determine the flow of nucleic acid detection information, special collection, special statistics, special reports, improve the efficiency and accuracy of information flow.

Refer to the above? Baidu Encyclopedia-A Guide for the Implementation of Nucleic Acid Testing Organizations in novel coronavirus (Second Edition)